Aurinia Pharmaceuticals to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference Biotech Investing
CEO Spotlight: Portage Biotech CEO Dr. Ian Walters Talks Asset Pipeline, Uplist, and Strategic Initiatives in a $20 Billion Sector Biotech Investing
Gilead Canada Announces Notice of Compliance for DESCOVY® for HIV Pre-exposure Prophylaxis Biotech Investing
Lexaria's Patented Technology Significantly Enhances Oral Delivery of Antiviral Drugs Biotech Investing
World's Leading Life Science Companies Now Enrolling COMMUNITY, A Global, Platform Trial For Hospitalized Patients With COVID-19 Biotech Investing
Algernon Pharmaceuticals Announces Enrollment of Final Patient in its Multinational Phase 2b/3 Human Study of Ifenprodil for COVID-19 Biotech Investing
